Antimicrobial Resistance in Neisseria Gonorrhoeae
Overview
Authors
Affiliations
The changing patterns of antimicrobial resistance in Neisseria gonorrhoeae have been reviewed regularly since the introduction of antimicrobial therapy in the 1930s. At present, ceftriaxone, fluoroquinolones, and spectinomycin have remained efficient as single-dose treatment of gonorrhea worldwide. To ensure that limited resources can be used in the best possible way, continuous surveillance of gonococcal resistance to antimicrobials is needed.
Kivata M, Mbuchi M, Eyase F, Bulimo W, Kyanya C, Oundo V BMC Infect Dis. 2020; 20(1):703.
PMID: 32977759 PMC: 7517623. DOI: 10.1186/s12879-020-05398-5.
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
Mlynarczyk-Bonikowska B, Majewska A, Malejczyk M, Mlynarczyk G, Majewski S Med Microbiol Immunol. 2019; 209(2):95-108.
PMID: 31802195 PMC: 7125254. DOI: 10.1007/s00430-019-00651-4.
Systematic review and meta-analysis on efficacy of cefixime for treating gonococcal infections.
Tanvir S, Qasim S, Shariq A, Najeeb S, Shah A Int J Health Sci (Qassim). 2018; 12(5):90-100.
PMID: 30202413 PMC: 6124830.
Penicillin's Discovery and Antibiotic Resistance: Lessons for the Future?.
Lobanovska M, Pilla G Yale J Biol Med. 2017; 90(1):135-145.
PMID: 28356901 PMC: 5369031.
Mugo P, Duncan S, Mwaniki S, Thiongo A, Gichuru E, Okuku H Sex Transm Infect. 2013; 89(7):583-9.
PMID: 23698510 PMC: 3812900. DOI: 10.1136/sextrans-2012-050979.